Jon B. Tornquist
25 IP cases indexed. Covers patent matters.
Cases Presided Over
25 cases indexed | Page 1 of 1
Texas Instruments Incorporated v.ParkerVision, Inc.
RPX's petition to invalidate ParkerVision's down-conversion patent was denied by the PTAB, which found no reasonable likelihood of success on the asserted anticipation and obviousness grounds.
HIKMA PHARMACEUTICALS USA INC. v.Axsome Malta Ltd. et al.
Hikma Pharmaceuticals filed an IPR against Axsome Malta’s 11,560,354 patent. The parties settled the dispute early and jointly moved to terminate the proceeding. The Board granted the motion and ordered the settlement agreement to be kept confidential.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
The PTAB denied Solus Advanced Materials' request for rehearing of its institution denial, finding the petition did not overcome the Fintiv factors, particularly the tight trial schedule. Institution of the IPR remains denied.
Padagis US LLC et al. v.Neurelis, Inc.
The PTAB held that all 36 claims of Neurelis' nasal benzodiazepine formulation patent are obvious over Gwozdz, Meezan ’962 and Cartt ’784, rendering the patent entirely unpatentable.
Apple Inc. v.RJ Technology LLC
The PTAB issued a Final Written Decision finding multiple claims of the patent unpatentable as obvious in view of prior art. The Board focused heavily on claim construction, specifically defining 'charge cut-off voltage' based on practical full-cell operation rather than just applied charging potential. Claims 2–4 and 6–18 were found invalid under 103.
Honeywell International Inc. v.DSM IP Assets, B.V. et al.
Honeywell International Inc.'s IPR challenge against DSM IP Assets, B.V. et al. was denied by the PTAB. The Board found that the Petitioner failed to meet the reasonable likelihood standard for obviousness over various prior art combinations in the field of biomedical devices and polymer fibers.
LG Energy Solution, Ltd. v.Molecular Rebar Design, LLC
LG Energy Solution successfully navigated the institution phase of an IPR, securing the continuation of its obviousness challenges against Molecular Rebar Design, LLC. The Board found a reasonable likelihood of prevailing on claims 1-8 over prior art references Ohata and Kavan.
LG Energy Solution, Ltd. v.Molecular Rebar Design, LLC
LG Energy Solution successfully instituted its IPR against Molecular Rebar Design, LLC's patent (9636649) covering polymer composites. The Board found a reasonable likelihood of obviousness across all 23 claims based on multiple prior art combinations.
LG Energy Solution, Ltd. v.Molecular Rebar Design, LLC
LG Energy Solution successfully petitioned to institute an IPR against Molecular Rebar Design, LLC's battery patent (8968924). The Board found sufficient evidence of obviousness over combinations of prior art references like Ohata and Kavan. This decision allows the challenge to proceed to a full trial phase at the PTAB.
LG Energy Solution, Ltd. v.Molecular Rebar Design, LLC
LG Energy Solution successfully convinced the PTAB that its obviousness challenges against Molecular Rebar Design's battery patent were strong enough for institution. The Board found sufficient evidence across multiple prior art combinations, leading to the IPR being instituted on all 16 claims.
LG Energy Solution, Ltd. v.Molecular Rebar Design, LLC
LG Energy Solution successfully secured the institution of its IPR against Molecular Rebar Design, LLC regarding lithium-ion battery technology. The Board found that Petitioner demonstrated a reasonable likelihood of prevailing on key claims despite arguments of obviousness over multiple prior art references.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
Solus Advanced Materials Co., Ltd.'s IPR challenge against SK nexilis Co., Ltd. was denied institution by the PTAB, despite a 'close call' on the merits. The denial hinged primarily on procedural factors related to scheduling and parallel litigation.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
Solus Advanced Materials Co., Ltd.'s request for rehearing was denied after the PTAB initially denied institution of IPR against SK nexilis Co., Ltd.'s copper foil patent, upholding the finding that obviousness claims lacked sufficient evidence.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
The PTAB denied Solus Advanced Materials' IPR challenges against SK nexilis regarding claims covering electrolytic copper foils for secondary batteries. The Board found that Petitioner failed to establish a reasonable likelihood of prevailing, particularly rejecting conclusory expert testimony used to bridge prior art gaps.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
The PTAB denied Solus Advanced Materials' request for rehearing, upholding the initial decision to deny institution of IPR against SK nexilis regarding surface roughness claims. The Board found insufficient evidence of motivation to combine prior art references.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
The PTAB denied the institution of an IPR challenge brought by Solus Advanced Materials Co., Ltd. against SK nexilis Co., Ltd.'s patent, finding insufficient evidence to support obviousness claims. The Board rejected the petitioner's reliance on hindsight bias when attempting to combine prior art references.
Solus Advanced Materials Co., Ltd. et al. v.SK nexilis Co., Ltd.
The PTAB institution decision found that the Petitioner demonstrated a reasonable likelihood of prevailing, instituting trial on all 10 claims. The grounds centered on obviousness (35 U.S.C. § 103), arguing that specific properties of electrolytic copper foil could be achieved by combining various prior art references.
Texas Instruments Incorporated v.Greenthread, LLC
Texas Instruments petitioned to challenge Greenthread’s semiconductor patent and sought joinder with a related IPR. The PTAB found a reasonable likelihood of unpatentability and granted both institution and joinder, merging the proceeding into IPR2023-01242.
Monolithic Power Systems, Inc. v.Greenthread, LLC
Monolithic Power Systems successfully obtained institution of an IPR against Greenthread’s 9,190,502 patent covering graded‑dopant semiconductor devices. The Board found a reasonable likelihood of unpatentability on claims 7 and 8 based on obviousness over Onoda, Nishizawa, and Kawagoe. The proceeding now moves to trial.
Padagis US LLC et al. v.Neurelis, Inc.
The PTAB held that all 36 claims of Neurelis’s intranasal benzodiazepine patent are obvious over prior art references Gwozdz, Meezan ’962, and Cartt ’784, rendering the patent entirely unpatentable.
Padagis US LLC et al. v.Neurelis, Inc.
The PTAB held that all 36 claims of Neurelis’s intranasal benzodiazepine patent are obvious over a combination of prior‑art references, rendering the patent entirely unpatentable.
Texas Instruments Incorporated v.Greenthread, LLC
Texas Instruments secured a joint IPR, expanding its challenge to Greenthread’s 10,510,842 patent covering graded dopant semiconductor devices. The Board instituted review of all 18 claims and approved the joinder, citing a reasonable likelihood of success and no prejudice to the existing proceeding.
Texas Instruments Incorporated v.Greenthread, LLC
The PTAB instituted an inter partes review of claim 44 of Greenthread’s ’222 patent, finding a reasonable likelihood of obviousness over Payne and over Sakai/Kawagoe. Texas Instruments’ motion to join the earlier IPR2023-01244 was also granted.
Monolithic Power Systems, Inc. v.Greenthread, LLC
Monolithic Power Systems successfully instituted an IPR against Greenthread’s 8,421,195 patent covering CMOS devices with graded dopant regions, citing obviousness over multiple prior‑art references.
Monolithic Power Systems, Inc. v.Greenthread, LLC
The PTAB instituted an IPR on claim 44 of Greenthread’s ’222 patent after finding a reasonable likelihood that Monolithic Power Systems would prevail, based on obviousness arguments over Onoda, Nishizawa, and Kawagoe.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.